Fresenius Medical Care Reports Q3 2025 Results
Ticker: FMCQF · Form: 6-K · Filed: Nov 4, 2025 · CIK: 1333141
| Field | Detail |
|---|---|
| Company | Fresenius Medical Care Ag (FMCQF) |
| Form Type | 6-K |
| Filed Date | Nov 4, 2025 |
| Risk Level | low |
| Pages | 2 |
| Reading Time | 2 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: earnings, results, foreign-private-issuer
TL;DR
FMS released Q3 results on Nov 4, 2025. Check the exhibits for the numbers.
AI Summary
On November 4, 2025, Fresenius Medical Care AG announced its third quarter results for the period ending September 30, 2025. The company issued a press release detailing these results, with financial figures provided as exhibits.
Why It Matters
This filing provides investors with the latest financial performance data for Fresenius Medical Care, crucial for understanding the company's current health and future prospects.
Risk Assessment
Risk Level: low — This is a routine earnings announcement, not indicating any unusual risks.
Key Players & Entities
- Fresenius Medical Care AG (company) — Registrant
- November 4, 2025 (date) — Date of Press Release
- September 30, 2025 (date) — End of Q3 reporting period
FAQ
What is the filing type and submission date?
This is a Form 6-K, filed on November 4, 2025.
What period do the announced results cover?
The results announced are for the third quarter ending September 30, 2025.
What is the company's central index key?
The company's central index key is 0001333141.
Where is Fresenius Medical Care AG headquartered?
Fresenius Medical Care AG is headquartered in Bad Homburg, Germany.
What exhibits are furnished with this 6-K filing?
Exhibit 99.1 is the Press Release announcing the Q3 results, and Exhibit 99.2 contains the corresponding financial figures.
Filing Stats: 568 words · 2 min read · ~2 pages · Grade level 15.8 · Accepted 2025-11-04 06:00:55
Filing Documents
- tm2528516d2_6k.htm (6-K) — 14KB
- tm2528516d2_ex99-1.htm (EX-99.1) — 66KB
- tm2528516d2_ex99-2.htm (EX-99.2) — 29KB
- tm2528516d2_ex99-2img001.jpg (GRAPHIC) — 75KB
- tm2528516d2_ex99-2img002.jpg (GRAPHIC) — 101KB
- tm2528516d2_ex99-2img003.jpg (GRAPHIC) — 158KB
- tm2528516d2_ex99-2img004.jpg (GRAPHIC) — 140KB
- tm2528516d2_ex99-2img005.jpg (GRAPHIC) — 79KB
- tm2528516d2_ex99-2img006.jpg (GRAPHIC) — 89KB
- tm2528516d2_ex99-2img007.jpg (GRAPHIC) — 45KB
- tm2528516d2_ex99-2img008.jpg (GRAPHIC) — 154KB
- tm2528516d2_ex99-2img009.jpg (GRAPHIC) — 50KB
- tm2528516d2_ex99-1img001.jpg (GRAPHIC) — 6KB
- tm2528516d2_ex99-1img002.jpg (GRAPHIC) — 97KB
- tm2528516d2_ex99-1img003.jpg (GRAPHIC) — 100KB
- tm2528516d2_ex99-1img004.jpg (GRAPHIC) — 129KB
- 0001104659-25-105811.txt ( ) — 1772KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized. DATE: November 4, 2025 Fresenius Medical Care AG By: /s/ Helen Giza Name: Helen Giza Title: Chief Executive Officer and Chair of the Management Board By: /s/ Martin Fischer Name: Martin Fischer Title: Chief Financial Officer and member of the Management Board